FGFR3 and FGFR4 overexpression in juvenile nasopharyngeal angiofibroma: impact of smoking history and implications for personalized management.

Autor: Safhi, Fatmah Ahmed, Al-Hazani, Tahani Mohamed Ibrahim, Jalal, Areej Saud, Alduwish, Manal Abdullah, Alshaya, Dalal S., Almufareh, Nawaf Abdulrahman, Domiaty, Dalia Mostafa, Alshehri, Eman, Al-Shamrani, Salha M., Abboosh, Tahani Saeed, Alotaibi, Mashael Alhumaidi, Alwaili, Maha Abdulla, Al-Qahtani, Wedad Saeed
Zdroj: Journal of Applied Genetics; Dec2023, Vol. 64 Issue 4, p749-758, 10p
Abstrakt: Lifestyle factors, including smoking, have been linked to neoplastic diseases, and reports suggest an association between smoking and overexpression of FGFR (fibroblast growth factor receptor) in certain neoplasms. This study aims to assess the expression of FGFR3 and FGFR4 genes in patients with and without a history of smoking. A total of 118 participants were recruited, including 83 Juvenile Nasopharyngeal Angiofibroma (JNA) patients and 35 healthy participants, the JNA patients were further stratified as smokers and nonsmokers. Total RNA was extracted from the blood & saliva sample by using TRIzol reagent, and quantified using a Nanodrop, and then subjected to gene expression analysis of FGFR3/4 using RT-PCR. Immunohistochemistry analysis was employed using fresh biopsies of JNA to validate the findings. All experiments were performed in triplicates and analysed using the Chi-Square test (P < 0.05). Smokers exhibited significantly lower total RNA concentrations across all sample types (P < 0.001). The study revealed significant upregulation of both FGFR3/4 genes in JNA patients (P < 0.05). Moreover, FGFR3 expression was significantly higher among smokers 66% (95% CI: 53–79%) compared to non-smokers 22% (95% CI: 18–26%). Immunohistochemistry analysis demonstrated moderate to strong staining intensity for FGFR3 among smokers. The study highlights the overexpression of FGFR3/4 genes in JNA patients, with a stronger association observed among smokers. Furthermore, medical reports indicated higher rates of recurrence and bleeding intensity among smokers. These findings emphasize the potential role of FGFR3 as a key molecular factor in JNA, particularly in the context of smoking. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: